Auxly Cannabis Group Stock Shares Outstanding

XLY Stock  CAD 0.07  0.01  6.67%   
Auxly Cannabis Group fundamentals help investors to digest information that contributes to Auxly Cannabis' financial success or failures. It also enables traders to predict the movement of Auxly Stock. The fundamental analysis module provides a way to measure Auxly Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Auxly Cannabis stock.
As of the 5th of March 2025, Common Stock Shares Outstanding is likely to grow to about 1.2 B.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Auxly Cannabis Group Company Shares Outstanding Analysis

Auxly Cannabis' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Auxly Cannabis Shares Outstanding

    
  1.25 B  
Most of Auxly Cannabis' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Auxly Cannabis Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Auxly Shares Outstanding Driver Correlations

Understanding the fundamental principles of building solid financial models for Auxly Cannabis is extremely important. It helps to project a fair market value of Auxly Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Auxly Cannabis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Auxly Cannabis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Auxly Cannabis' interrelated accounts and indicators.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Auxly Common Stock Shares Outstanding

Common Stock Shares Outstanding

1.2 Billion

At this time, Auxly Cannabis' Common Stock Shares Outstanding is very stable compared to the past year.
Based on the latest financial disclosure, Auxly Cannabis Group has 1.25 B of shares currently outstending. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares outstanding for all Canada stocks is 119.15% lower than that of the firm.

Auxly Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Auxly Cannabis' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Auxly Cannabis could also be used in its relative valuation, which is a method of valuing Auxly Cannabis by comparing valuation metrics of similar companies.
Auxly Cannabis is currently under evaluation in shares outstanding category among its peers.

Auxly Cannabis Current Valuation Drivers

We derive many important indicators used in calculating different scores of Auxly Cannabis from analyzing Auxly Cannabis' financial statements. These drivers represent accounts that assess Auxly Cannabis' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Auxly Cannabis' important valuation drivers and their relationship over time.
202020212022202320242025 (projected)
Market Cap161.0M144.9M17.8M9.9M8.9M8.5M
Enterprise Value264.5M320.3M196.8M153.3M138.0M80.5M

Auxly Fundamentals

About Auxly Cannabis Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Auxly Cannabis Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Auxly Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Auxly Cannabis Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Other Information on Investing in Auxly Stock

Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.